Coronary disease & ACS

High-Output Mechanical Circulatory Support in Left Main Interventions: The Magenta Elevate High-Risk PCI First-in-Human Study

JACC Cardiovasc IntervPublished First-in-human study

Authors' conclusion

In this first-in-human study, use of the Magenta Elevate low-profile, high-output catheter during HR-PCI was safe and provided substantial cardiac support. During prolonged interventional LM occlusions, the system unloaded the LV, maintaining a normal MAP and dΔPAoLV.

Study context

Population
Patients undergoing high-risk percutaneous coronary intervention (HR-PCI), including prolonged unprotected left main balloon occlusions8 with LM occlusions
Participants
14 patients
Outcome
Major device-related adverse events (primary safety endpoint)

Main finding

As reported in the abstract

  • No major device-related adverse events

Further findings

OutcomeChange (mm Hg) (CI)P value
Haemodynamic change during prolonged LM occlusions (20 occlusions)During occlusionvs Before occlusionSystolic aortic pressure−35 (−46 to −23)P < 0.0001
Haemodynamic change during prolonged LM occlusions (20 occlusions)During occlusionvs Before occlusionDiastolic pressure7 (4–10)P < 0.0055
Haemodynamic change during prolonged LM occlusions (20 occlusions)During occlusionvs Before occlusionMAP; remained in normal range−7 (−13 to −2)P < 0.001
Haemodynamic change during prolonged LM occlusions (20 occlusions)During occlusionvs Before occlusiondΔPAoLV; remained in normal range−2 (−5 to 4)P = 0.51
Haemodynamic change during prolonged LM occlusions (20 occlusions) — Ventriculo-arterial uncoupling
13 of 20 LM balloon occlusions

Mortality · 30 days

No mortality at 30 days

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

High-Output Mechanical Circulatory Support in Left Main Interventions: The Magenta Elevate High-Risk PCI First-in-Human Study. JACC Cardiovasc Interv. Published 23 December 2024. doi:10.1016/j.jcin.2024.09.017

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.